Burning Rock Biotech BNR Institutional Ownership

Updated Oct 11, 2026

Burning Rock Biotech Ltd (NASDAQ:BNR) counted 17 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• Together they owned 16.51% of the outstanding stock in Q2 2026, up from 16.26% a quarter earlier.
• Total shares held in Burning Rock Biotech rose 1.51% versus Q1 2026, while the number of holders rose 13.33% versus Q2 2025.
• Looking at the 17 holders of BNR individually, 9 added to their positions, 4 reduced their stakes and 4 left their positions unchanged.
• The aggregate institutional position in Burning Rock Biotech was 1.74Mn shares at the end of Q2 2026, up 25.77K from the prior quarter and up 333.02K from a year earlier.
• As of June 30, 2026, the biggest holder of Burning Rock Biotech was Kynam Capital Management, LP with 1.24Mn shares, or 11.78% of shares outstanding.
• Among holders that already owned Burning Rock Biotech, the biggest buyers in Q2 2026 were Morgan Stanley (+28.32K shares), UBS Group AG (+17.51K shares), Renaissance Technologies LLC (+17.43K shares), Kynam Capital Management, LP (+11.01K shares) and Citadel Advisors LLC (+9.62K shares).
• The largest position reductions in BNR for Q2 2026 were by CRCM LP (-70.1K shares), Sumitomo Mitsui Trust Group, Inc. (-413 shares), Amova Asset Management Americas, Inc. (-413 shares) and JPMorgan Chase & Co (-21 shares).
• Per Business Quant, the top 10 investors in BNR for the quarter ended June 30, 2026 were Kynam Capital Management, LP (1.24Mn shares), CRCM LP (212K shares), Renaissance Technologies LLC (52.84K shares), Morgan Stanley (43.59K shares), Sumitomo Mitsui Trust Group, Inc. (29.72K shares), Amova Asset Management Americas, Inc. (29.72K shares), Bank of America Corp (29.16K shares), Citadel Advisors LLC (27.29K shares), HSG Holding Ltd (21.21K shares) and UBS Group AG (17.92K shares).